• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Q&A: What is corneal hysteresis?

Video

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part one.

Ahead of his technology article in the July 2022 issue of Optometry Times®, Thomas A. Wong, OD, FNAP, associate clinical professor of SUNY Optometry, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, both members of the SUNY Optometry class of 2022, discuss corneal hysteresis.

This transcript has been lightly edited for clarity:

What is corneal hysteresis?

Elise Regina, OD:

So corneal hysteresis is measuring the visco elasticity of the corneal tissue. Why we're talking about the cornea with glaucoma, so we can't directly measure anything in the back of the eye near the optic nerve, which is what we're concerned about with glaucoma. But there is a lot of hypothesis around the corneal tissue biomechanics being related to the lamina cribrosa, as well as the peripapillary sclera.

Related: Corneal hysteresis and biomechanics growing in diagnostic importance

So, if someone has a low corneal hysteresis, they may be a little more, there might be a higher chance that they're lamina cribrosa can't withstand high IOP fluctuations, or anything like that, so there might be a higher risk of optic nerve damage in people with lower corneal hysteresis and there might be a higher risk of glaucoma progression in people that are already diagnosed.

Related Videos
Lorraine Provencher, MD, presenting slides
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
Shelley Cutler, OD, FAAO, outlines her key takeaways from this year's IKA symposium
© 2024 MJH Life Sciences

All rights reserved.